Design and Evaluation of Compritol-Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy.

Nadir A, Afridi S, Nishan U, Lv S, Boyaci İ, Muhammad F, Ullah Z, Junaid M, Tariq A, Khan H, Usman M, Javed A, Rahman AA, Anwar K, Fawy KF, Khan A

Open source

DOI
10.1096/fj.202603856r
Published
2026 Nov 15
Container
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1096/fj.202603856r,
  title = {Design and Evaluation of Compritol-Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy.},
  author = {Nadir A and Afridi S and Nishan U and Lv S and Boyaci İ and Muhammad F and Ullah Z and Junaid M and Tariq A and Khan H and Usman M and Javed A and Rahman AA and Anwar K and Fawy KF and Khan A},
  year = {2026},
  journal = {FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
  doi = {10.1096/fj.202603856r},
  url = {https://doi.org/10.1096/fj.202603856r}
}

RIS

TY  - JOUR
TI  - Design and Evaluation of Compritol-Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy.
AU  - Nadir A
AU  - Afridi S
AU  - Nishan U
AU  - Lv S
AU  - Boyaci İ
AU  - Muhammad F
AU  - Ullah Z
AU  - Junaid M
AU  - Tariq A
AU  - Khan H
AU  - Usman M
AU  - Javed A
AU  - Rahman AA
AU  - Anwar K
AU  - Fawy KF
AU  - Khan A
PY  - 2026
JO  - FASEB journal : official publication of the Federation of American Societies for Experimental Biology
DO  - 10.1096/fj.202603856r
UR  - https://doi.org/10.1096/fj.202603856r
ER  - 

APA

A, N., S, A., U, N., S, L., İ, B., F, M., Z, U., M, J., A, T., H, K., M, U., A, J., AA, R., K, A., KF, F., & A, K. (2026). Design and Evaluation of Compritol-Oleic Acid Nanostructured Lipid Carriers: A New Approach to Type 2 Diabetes Therapy.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. https://doi.org/10.1096/fj.202603856r

Source records